COMMUNIQUÉS West-GlobeNewswire
-
Intuitive Collaborates with Deion “Coach Prime” Sanders to Raise Patient Awareness of Surgical Options
27/07/2026 -
Applied Biologics Announces Extension of Longstanding System-Wide Agreement With Providence Health & Services for XWRAP®
27/07/2026 -
HealthEx Launches HealthEx Wallet, a Secure App for Individuals to Access, Understand, and Manage Their Health Records
27/07/2026 -
Rose Hill Life Sciences Appoints Jama Pitman as Chief Executive Officer
27/07/2026 -
Oktopi secures follow-on funding to expand OktoPilot's AI-informed capabilities, building on the inaugural global health grant
27/07/2026 -
HealthEx to Help Americans Bring Their Medical Records into AskMD by Sharecare
27/07/2026 -
Landmark 10-Year Study Strengthens Long-Term Evidence Supporting Focal Therapy
27/07/2026 -
Capricor Comments on Briefing Materials Ahead of July 29 FDA Advisory Committee Meeting for Deramiocel
27/07/2026 -
Revagenix Doses First Participant in Phase 1 Trial of Rev-56, an Inhaled Therapy for Non-CF Bronchiectasis
27/07/2026 -
Vadma Institute Expands Global Practitioner Certification Program as Interest Grows in Its Neuro-Somatic Wellness Method
27/07/2026 -
Zealand Pharma - Transactions related to share buy-back program (week 30, 2026)
27/07/2026 -
Vivos Inc. (OTCQB: RDGL) Reports Second Quarter 2026 Progress and Corporate Update - Correction
27/07/2026 -
CurePSP Invests in the Next Generation of PSP and CBD Researchers with Student Fellowship Awards
27/07/2026 -
Parexel Recognized as a World’s Top Disability Inclusive Business by the Disability Index® from Disability:IN
27/07/2026 -
SafeSpace Global Announces AI-Powered Senior Living Safety Pilot with Blakeford at Green Hills
27/07/2026 -
Assisting Hands Home Care Frisco Trains Caregivers in Stroke Recovery, Brings Post-Stroke Education to North Texas Families
27/07/2026 -
Lexicon Pharmaceuticals Completes Enrollment of Pivotal Phase 3 SONATA-HCM Study of Sotagliflozin in Symptomatic Non-Obstructive and Obstructive Hypertrophic Cardiomyopathy (HCM)
27/07/2026 -
Medicus Pharma Receives FDA “Study May Proceed” Letter for NDA-Enabling Registrational SkinJect® Study in Patients with Gorlin Syndrome
27/07/2026 -
Pluristyx Partners With Leading Regenerative Medicine and Aerospace Pioneers to Standardize Clinical-Grade Hepatocyte Manufacturing for Space and Earth Applications
27/07/2026
Pages